| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.11B | 127.39B | 127.06B | 153.33B | 148.13B | 136.16B |
| Gross Profit | 57.62B | 46.64B | 46.24B | 60.65B | 58.49B | 50.70B |
| EBITDA | 33.77B | 26.56B | 24.68B | 39.11B | 39.20B | 32.29B |
| Net Income | 18.53B | 10.91B | 10.44B | 20.45B | 21.19B | 17.17B |
Balance Sheet | ||||||
| Total Assets | 267.89B | 244.29B | 250.94B | 254.17B | 243.31B | 224.67B |
| Cash, Cash Equivalents and Short-Term Investments | 47.95B | 59.78B | 64.65B | 64.12B | 67.06B | 62.03B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 37.67B | 25.61B | 22.66B | 29.06B | 34.53B | 30.11B |
| Stockholders Equity | 230.08B | 218.56B | 228.16B | 224.99B | 208.66B | 194.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.89B | 15.54B | 2.20B | 5.53B | 22.94B |
| Operating Cash Flow | 0.00 | 23.41B | 30.19B | 12.99B | 15.72B | 30.87B |
| Investing Cash Flow | 0.00 | -11.42B | -12.37B | -5.78B | -11.60B | -10.47B |
| Financing Cash Flow | 0.00 | -16.20B | -17.15B | -7.95B | -6.51B | -4.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥340.43B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
71 Outperform | ¥542.64B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
68 Neutral | ¥511.45B | 11.30 | 6.46% | 2.22% | 12.95% | 46.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥279.15B | 8.88 | 7.67% | 0.91% | 9.03% | 10.76% | |
58 Neutral | ¥399.97B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥593.82B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |